INS and gestational diabetes: All 20 participants with T1D used insulin (15 via continuous subcutaneous insulin infusion and 5 via multiple daily injections [MDI]); 2 out of the 3 with T2D used insulin (both via MDI); and 4 out of the 9 with GDM used insulin (all via MDI).